Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s traded shares stood at 2.91 million during the last session, with the company’s beta value hitting 0.83. At the close of trading, the stock’s price was $0.52, to imply an increase of 25.07% or $0.1 in intraday trading. The ASBP share’s 52-week high remains $15.80, putting it -2938.46% down since that peak but still an impressive 57.69% since price per share fell to its 52-week low of $0.22. The company has a valuation of $25.72M, with an average of 1.34 million shares in intraday trading volume over the past 10 days and average of 14.98 million shares over the past 3 months.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information

After registering a 25.07% upside in the last session, Aspire Biopharma Holdings Inc (ASBP) has traded red over the past five days. The 5-day price performance for the stock is 45.87%, and 90.71% over 30 days. With these gigs, the year-to-date price performance is -95.23%. Short interest in Aspire Biopharma Holdings Inc (NASDAQ:ASBP) saw shorts transact 2.42 million shares and set a 0.32 days time to cover.

ASBP Dividends

Aspire Biopharma Holdings Inc has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders

Aspire Biopharma Holdings Inc insiders hold 33.08% of total outstanding shares, with institutional holders owning 4.16% of the shares at 6.22% float percentage. In total, 4.16% institutions holds shares in the company.